Literature DB >> 31686372

Beta-Amyloid Increases the Expression Levels of Tid1 Responsible for Neuronal Cell Death and Amyloid Beta Production.

Chunyu Zhou1, Ferdous Taslima1, Mona Abdelhamid1, Sung-Woo Kim2, Hiroyasu Akatsu3, Makoto Michikawa4, Cha-Gyun Jung5.   

Abstract

Mitochondrial dysfunctions and oxidative stress play important roles in the early pathogenesis of Alzheimer's disease (AD), which also involves the aberrant expression levels of mitochondrial proteins. However, the molecular mechanisms underlying the aberrant expression levels of these proteins in the pathogenesis of AD are still not completely understood. Tid1 (DnaJA3/mtHsp40), a mammalian homolog of the Drosophila tumor suppressor Tid56, is reported to induce mitochondrial fragmentation associated with an increase in reactive oxygen species (ROS) levels, resulting in cell death in some cancer cells. However, the involvement of Tid1 in AD pathogenesis is as yet unknown. In this study, we found that the Tid1 protein levels were upregulated in the hippocampus of AD patients and Tg2576 mice. Our in vitro studies showed that Aβ42 increased the expression levels of Tid1 in primary rat cortical neurons. The knockdown of Tid1 protected against neuronal cell death induced by Aβ42, and Tid1-mediated neuronal cell death, was dependent on the increased ROS generation and caspase-3 activity. The overexpression of Tid1 in HEK293-APP cells increased the BACE1 levels, resulting in increased Aβ production. Conversely, Tid1 knockdown in HEK293-APP cells and primary cultured neurons decreased Aβ production through the reduction in the BACE1 levels. We also found that the overexpression of Tid1 activated c-Jun N-terminal kinase (JNK) leading to increased Aβ production. Taken together, our results suggest that upregulated Tid1 levels in the hippocampus of patients with AD and Tg2576 mice induce apoptosis and increase Aβ production, and Tid1 may therefore be a suitable target in therapeutic interventions for AD.

Entities:  

Keywords:  Alzheimer’s disease; BACE1; JNK; Mitochondrial protein; Neuronal cell death; ROS; Tid1; β-Amyloid

Mesh:

Substances:

Year:  2019        PMID: 31686372     DOI: 10.1007/s12035-019-01807-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  60 in total

1.  Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

Authors:  R M Damian Holsinger; Catriona A McLean; Konrad Beyreuther; Colin L Masters; Geneviève Evin
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

2.  Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.

Authors:  X Zhu; A K Raina; C A Rottkamp; G Aliev; G Perry; H Boux; M A Smith
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

Review 3.  Mitochondrial proteostasis in the context of cellular and organismal health and aging.

Authors:  Erica A Moehle; Koning Shen; Andrew Dillin
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

4.  Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

Authors:  Christopher D Aluise; Renã A Sowell Robinson; Tina L Beckett; M Paul Murphy; Jian Cai; William M Pierce; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2010-04-23       Impact factor: 5.996

Review 5.  Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  Brain Pathol       Date:  2004-10       Impact factor: 6.508

6.  Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.

Authors:  B Puig; T Gómez-Isla; E Ribé; M Cuadrado; B Torrejón-Escribano; E Dalfó; I Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090

7.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Authors:  Hiroaki Fukumoto; Bonnie S Cheung; Bradley T Hyman; Michael C Irizarry
Journal:  Arch Neurol       Date:  2002-09

8.  Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage.

Authors:  Jake G Hoekstra; Michael J Hipp; Thomas J Montine; Scott R Kennedy
Journal:  Ann Neurol       Date:  2016-07-13       Impact factor: 10.422

9.  Cell cycle activation linked to neuronal cell death initiated by DNA damage.

Authors:  Inna I Kruman; Robert P Wersto; Fernando Cardozo-Pelaez; Lubomir Smilenov; Sic L Chan; Francis J Chrest; Roland Emokpae; Myriam Gorospe; Mark P Mattson
Journal:  Neuron       Date:  2004-02-19       Impact factor: 17.173

10.  Amyloid-Beta interaction with mitochondria.

Authors:  Lucia Pagani; Anne Eckert
Journal:  Int J Alzheimers Dis       Date:  2011-03-15
View more
  6 in total

Review 1.  Recent insights into the role of glia and oxidative stress in Alzheimer's disease gained from Drosophila.

Authors:  Lindsey D Goodman; Hugo J Bellen
Journal:  Curr Opin Neurobiol       Date:  2021-08-18       Impact factor: 6.627

2.  Sustained high body temperature exacerbates cognitive function and Alzheimer's disease-related pathologies.

Authors:  Cha-Gyun Jung; Reiko Kato; Chunyu Zhou; Mona Abdelhamid; Esraa Ibrahim A Shaaban; Hitoshi Yamashita; Makoto Michikawa
Journal:  Sci Rep       Date:  2022-07-18       Impact factor: 4.996

Review 3.  Putting human Tid-1 in context: an insight into its role in the cell and in different disease states.

Authors:  Sagarika Banerjee; Rupesh Chaturvedi; Anu Singh; Hemant R Kushwaha
Journal:  Cell Commun Signal       Date:  2022-07-19       Impact factor: 7.525

4.  The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model.

Authors:  Dongming Wu; Xiaopeng Wang; Ye Han; Yayun Wang
Journal:  BMC Genomics       Date:  2021-12-13       Impact factor: 3.969

5.  Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer's Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation.

Authors:  Chunyu Zhou; Cha-Gyun Jung; Mi-Jeong Kim; Atsushi Watanabe; Mona Abdelhamid; Ferdous Taslima; Makoto Michikawa
Journal:  Mol Neurobiol       Date:  2022-06-15       Impact factor: 5.682

6.  Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease.

Authors:  Fan'ge Kong; Xue Jiang; Ruochen Wang; Siyu Zhai; Yizhi Zhang; Di Wang
Journal:  J Neuroinflammation       Date:  2020-10-15       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.